Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by ...

The U.K. cost-effectiveness standard for drugs will increase by 25% in exchange for zero tariffs on the country’s ...

Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a pivotal ...

As employers brace for significant healthcare cost increases in 2026, many are seeking out innovative strategies to manage the impact. This comes from the Business Group on Health’s newly released ...

Digital solutions have greatly expanded access to mental health support, though they’re not always reaching the people who need it the most, such as youth in rural, low-income and marginalized ...

Johnson & Johnson is adding to its oncology pipeline with a $3.05 billion deal to acquire Halda Therapeutics, a startup whose first-in-class approach to prostate cancer could overcome drug resistance ...

One of the hotter areas of cancer drug research involves using a particular type of bispecific antibody as the backbone for therapeutic combinations intended to bring a multi-pronged attack to tumors.

Congress created Health Savings Accounts and Flexible Spending Accounts to empower Americans with control over their healthcare spending. The accounts were designed to allow individuals to use pre-tax ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

Ostro’s effort to boost the country’s less-than-stellar health literacy earned the startup a place in the Guinness World Records this week. The company’s virtual course now holds the record for the ...

In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.